Skip Navigation
Skip to contents

Cancer Res Treat : Cancer Research and Treatment

OPEN ACCESS

Search

Page Path
HOME > Search
1 "Cremophor EL-free"
Filter
Filter
Article category
Keywords
Publication year
Authors
Funded articles
Original Article
An Open-Label, Randomized, Parallel, Phase III Trial Evaluating the Efficacy and Safety of Polymeric Micelle-Formulated Paclitaxel Compared to Conventional Cremophor EL-Based Paclitaxel for Recurrent or Metastatic HER2-Negative Breast Cancer
In Hae Park, Joo Hyuk Sohn, Sung Bae Kim, Keun Seok Lee, Joo Seop Chung, Soo Hyeon Lee, Tae You Kim, Kyung Hae Jung, Eun Kyung Cho, Yang Soo Kim, Hong Suk Song, Jae Hong Seo, Hun Mo Ryoo, Sun Ah Lee, So Young Yoon, Chul Soo Kim, Yong Tai Kim, Si Young Kim, Mi Ryung Jin, Jungsil Ro
Cancer Res Treat. 2017;49(3):569-577.   Published online September 12, 2016
DOI: https://doi.org/10.4143/crt.2016.289
AbstractAbstract PDFPubReaderePub
Purpose
Genexol-PM is a Cremophor EL–free formulation of low-molecular-weight, non-toxic, and biodegradable polymeric micelle-bound paclitaxel. We conducted a phase III study comparing the clinical efficacy and toxicity of Genexol-PM with conventional paclitaxel (Genexol).
Materials and Methods
Patients were randomly assigned (1:1) to receive Genexol-PM 260 mg/m2 or Genexol 175 mg/m2 intravenously every 3 weeks. The primary outcome was the objective response rate (ORR).
Results
The study enrolled 212 patients, of whom 105 were allocated to receive Genexol-PM. The mean received dose intensity of Genexol-PM was 246.8±21.3 mg/m2 (95.0%), and that of Genexol was 168.3±10.6 mg/m2 (96.2%). After a median follow-up of 24.5 months (range, 0.0 to 48.7 months), the ORR of Genexol-PM was 39.1% (95% confidence interval [CI], 31.2 to 46.9) and the ORR of Genexol was 24.3% (95% CI, 17.5 to 31.1) (pnon-inferiority=0.021, psuperiority=0.016). The two groups did not differ significantly in overall survival (28.8 months for Genexol-PM vs. 23.8 months for Genexol; p=0.52) or progression-free survival (8.0 months for Genexol-PM vs. 6.7 months for Genexol; p=0.26). In both groups, the most common toxicities were neutropenia, with 68.6% occurrence in the Genexol-PM group versus 40.2% in the Genexol group (p < 0.01). The incidences of peripheral neuropathy of greater than grade 2 did not differ significantly between study treatments.
Conclusion
Compared with standard paclitaxel, Genexol-PM demonstrated non-inferior and even superior clinical efficacy with a manageable safety profile in patients with metastatic breast cancer.

Citations

Citations to this article as recorded by  
  • Overcoming resistance: targeted nanomedicine solutions for cancer therapy
    Bhaveshkumar Patel, Ankur Vashi, Akhilesh Kumar Kuril, Praveen Kumar Subbappa, Ramakrishna Borra
    Journal of Biomaterials Science, Polymer Edition.2026; 37(6): 1193.     CrossRef
  • Innovations in targeted drug delivery: From nanotechnology to clinical applications
    Akash Srivastava, Asad Ahmad, Shaiber Siddiqui, Anas Islam
    Next Nanotechnology.2026; 9: 100336.     CrossRef
  • Regulatory framework for polymer-based nanotherapeutics in clinical translation
    Federico Stucchi, Min Li, Giuseppe Castellano, Francesco Cellesi
    Frontiers in Bioengineering and Biotechnology.2026;[Epub]     CrossRef
  • Advances in Polymer Micelles for Cancer Therapy: From Conventional to Smart Delivery Systems
    Rayna Georgieva Bryaskova, Krasimir Georgiev Staykov, Damyan Stoyanov Ganchev
    Pharmaceutics.2026; 18(2): 177.     CrossRef
  • The Current Landscape of Nanopaclitaxel Formulations and the Benefits of Polymeric Micellar Paclitaxel in Solid Tumors
    Vaibhav Choudhary, Nirmal Raut, Gajanan Panchal, Maneesha Khalse, Kamlesh Patel
    Indian Journal of Medical and Paediatric Oncology.2026;[Epub]     CrossRef
  • Clinical advances and challenges of antibody-mediated targeted drug delivery in breast cancer therapeutics
    Mokhtar Rejili
    Discover Oncology.2026;[Epub]     CrossRef
  • Recent paclitaxel formulation strategies: expanding the therapeutic index by addressing biopharmaceutical and toxicity limitations
    Jihoon Lee, Min-Koo Choi, Im-Sook Song
    Archives of Pharmacal Research.2026; 49(4): 500.     CrossRef
  • Personalized Nanomedicine: Integrating Molecular Stratification with Engineered Delivery Systems
    Segev Sharon, Gayatri Mainkar, Lior Zangi
    Journal of Nanotheranostics.2026; 7(2): 9.     CrossRef
  • In vitro Anticancer Activity of Flaxseed Oil Loaded-Polymeric Micelles in Breast Cancer Cell Line
    Eda Nur Yetiskin Morkan, Maria Daaboul, Shifa Alhamvi, Gulsah Akbas, Banu Mansuroglu, Murat Topuzogullari
    Brazilian Archives of Biology and Technology.2026;[Epub]     CrossRef
  • Disrupting the metastatic cascade: nanoparticle-based innovations in antimetastatic therapy
    Tamara Meňhertová, Martina Raudenská, Michal Masařík, Michaela Fojtů
    Nanoscale Horizons.2026;[Epub]     CrossRef
  • Revolutionizing cancer treatment: ROS-induced apoptosis via nanoformulated alkaloids
    Swathi Putta, Santhosh Kumar Chinnaiyan, Ramadevi Korni, Venkata Radha Gadela
    Journal of Drug Delivery Science and Technology.2025; 104: 106556.     CrossRef
  • A drug-eluting balloon catheter coated with chitosan and paclitaxel-loaded poloxamer-stabilized PLA microparticles for the effective treatment of cholangiocarcinoma
    Jin Sil Lee, Jaehee Jang, Hyeryeon Oh, Eunhye Lee, Don Haeng Lee, Panmo Son, Daekyung Sung, Won Il Choi
    Journal of Industrial and Engineering Chemistry.2025; 150: 357.     CrossRef
  • Nanomicellar Prodrug Delivery of Glucose-Paclitaxel: A Strategy to Mitigate Paclitaxel Toxicity
    Didi Yan, Xinyue Ma, Yixin Hu, Guogang Zhang, Beibei Hu, Bo Xiang, Xiaokun Cheng, Yongshuai Jing, Xi Chen
    International Journal of Nanomedicine.2025; Volume 20: 2087.     CrossRef
  • Emerging phytochemical-based nanocarriers: redefining the perspectives of breast cancer therapy
    Gulshan Sharma, Rohil Panwar, Sanskriti Saini, Hardeep Singh Tuli, Karan Wadhwa, Rakesh Pahwa
    Naunyn-Schmiedeberg's Archives of Pharmacology.2025; 398(9): 11199.     CrossRef
  • Integrating Nanoparticles and Herbal Extracts with Platinum-Based Chemotherapy for Enhanced Efficacy and Reduced Toxicity (A Review)
    Palash Chandra Biswas, Vikash Jakhmola, Arnab Samanta, Anandi Kapri, Arif Nur Muhammad Ansori, Rahadian Zainul
    Pharmaceutical Chemistry Journal.2025; 59(2): 159.     CrossRef
  • Clinical cancer nanomedicines
    Roger M. Pallares, Roman A. Barmin, Alec Wang, Fabian Kiessling, Twan Lammers
    Journal of Controlled Release.2025; 385: 113991.     CrossRef
  • Advances in paclitaxel nanoformulations: A systematic review of in vivo therapeutic efficacy and safety enhancements
    Salma Seyam, Batoul Alallam, Nurdianah Harif Fadzilah, Erazuliana Abd Kadir
    Journal of Controlled Release.2025; 385: 114036.     CrossRef
  • Poly (ortho esters) (POEs) as cutting-edge biodegradable polymers for targeted cancer treatment and overcoming multidrug resistance
    Devansh Shah, Sankha Bhattacharya
    Biomedical Materials.2025; 20(4): 042004.     CrossRef
  • Paclitaxel-based strategy as first-line therapy for advanced breast cancer: a model-based economic evaluation for China
    Ji-Sheng Chen, Jia Hu, Meng-Ting Li
    Future Oncology.2025; 21(23): 3005.     CrossRef
  • Nanocarrier-based insulin delivery: A leap towards a needle-free future
    Saranya Balasubramaniyam, Thirumalaikumaran Rathinam, Mohanakrishnan Srinivasan, Sowmiya Jayarani
    Nano TransMed.2025; 4: 100093.     CrossRef
  • Nanotechnology-enhanced phytomedicines: Innovations and applications in cancer therapy
    Rajesh Kumar, Seetha Harilal, Swati Arora, Swati Mohanty, Sumit Sheoran, Jyoti Sangwan, Divya Kanojiya, Ankita Acharya, Trideep Saikla
    International Immunopharmacology.2025; 166: 115537.     CrossRef
  • Smart pH-Responsive polymers in biomedical Applications: Nanoparticles, hydrogels, and emerging hybrid platforms
    Giuseppe Nunziata, Domenico Pollonio, Elisa Lacroce, Filippo Rossi
    Materials Today Chemistry.2025; 49: 103063.     CrossRef
  • Gemcitabine and Cisplatin Plus Polymeric Micellar Paclitaxel and Survival in Advanced Biliary Tract Cancer
    Hyehyun Jeong, Changhoon Yoo, Ilhwan Kim, Jung Hun Kang, Jae Ho Jeong, Kwonoh Park, Sang-Bo Oh, Inkeun Park, Sun Jin Sym, Jaekyung Cheon, Hyewon Ryu, Jun Eul Hwang, Ji Sung Lee, Baek-Yeol Ryoo, Kyu-pyo Kim
    JAMA Network Open.2025; 8(10): e2534560.     CrossRef
  • Advances in PCL, PLA, and PLGA-Based Technologies for Anticancer Drug Delivery
    Yeongbeom Kim, Jaewoo Kwak, Minyeong Lim, Su Yeon Lim, Sehyun Chae, Suk-Jin Ha, Young-Wook Won, Hyun-Ouk Kim, Kwang Suk Lim
    Pharmaceutics.2025; 17(10): 1354.     CrossRef
  • From Conventional to Next-Generation Strategies: Recent Advances in Polymeric Micelle Preparation for Drug Delivery
    Suhyeon Cho, Morteza Rasoulianboroujeni, Rae Hyung Kang, Glen S. Kwon
    Pharmaceutics.2025; 17(10): 1360.     CrossRef
  • Navigating Cancer Treatment: A Journey from 2D to 3D Cancer Models and Nanoscale Therapies
    Navneet Kaur, Mary Jean Savitsky, Annie Scutte, Roshani Mehta, Narjes Dridi, Taiwo Sogbesan, Alexyss Savannah, Damian Lopez, Dazhi Yang, Jamel Ali
    ACS Pharmacology & Translational Science.2025; 8(11): 3773.     CrossRef
  • Beyond nanomicelles and hydrogels: exploring micelle-containing hydrogels as cutting-edge drug delivery system for effective breast cancer treatment
    Ananya Bishnoi, Gunjan Vasant Bonde
    International Journal of Pharmaceutics.2025; 686: 126307.     CrossRef
  • Nanoparticle polymeric micellar paclitaxel compared with paclitaxel for advanced esophageal squamous cell carcinoma
    Yu‐Qing Cao, Meng Song, Bing‐jie Xue, Fei‐Yu Wang, Xiang‐Ming Huang, Jie Cao, Ai‐Guo Cao, Xin‐En Huang
    Precision Medical Sciences.2025;[Epub]     CrossRef
  • Label-Free Analysis Reveals In Vivo Premature Drug Release Governed by Diffusion from Polymeric Micelles
    Jiayi Yao, Jiefang Sun, Xinyi Wang, Haoran Wang, Yuqi Liu, Mingyang Zhao, Xiangjun Meng, Jingkai Gu
    Nano Letters.2025; 25(52): 18132.     CrossRef
  • Administration of Inhibitory Molecules through Nanoparticles in Breast Cancer Therapy
    Christian Rafael Quijia, Andreina Quevedo Enríquez, Carlos Daniel Zappia, Roxana Noemí Peroni, Marlus Chorilli
    Current Medicinal Chemistry.2024; 31(6): 726.     CrossRef
  • Innovative strategies for effective paclitaxel delivery: Recent developments and prospects
    Sławomir Wileński, Agnieszka Koper, Paulina Śledzińska, Marek Bebyn, Krzysztof Koper
    Journal of Oncology Pharmacy Practice.2024; 30(2): 367.     CrossRef
  • Effect of zwitterionic sulfobetaine incorporation on blood behaviours, phagocytosis, and in vivo biodistribution of pH-responsive micelles with positive charges
    Chengwei Wang, Hao Liu, Hu Lin, Rui Zhong, Hao Li, Jiaxin Liu, Xianglin Luo, Meng Tian
    Journal of Materials Chemistry B.2024; 12(6): 1652.     CrossRef
  • Reexamining in vivo fate of paclitaxel-loaded polymeric micelles
    Shiqi Lin, Yifei Yu, Ercan Wu, Tianhao Ding, Yuxiu Chu, Feng Pan, Yang Yang, Changyou Zhan
    Nano Today.2024; 56: 102255.     CrossRef
  • Functionalized Polymeric Micelles for Targeted Cancer Therapy: Steps from Conceptualization to Clinical Trials
    Ana Serras, Célia Faustino, Lídia Pinheiro
    Pharmaceutics.2024; 16(8): 1047.     CrossRef
  • Polyester nanoparticles delivering chemotherapeutics: Learning from the past and looking to the future to enhance their clinical impact in tumor therapy
    Giuseppe Longobardi, Thomas Lee Moore, Claudia Conte, Francesca Ungaro, Ronit Satchi‐Fainaro, Fabiana Quaglia
    WIREs Nanomedicine and Nanobiotechnology.2024;[Epub]     CrossRef
  • Research progress of paclitaxel nanodrug delivery system in the treatment of triple-negative breast cancer
    Jia-xin Qiao, Dong-yan Guo, Huan Tian, Zhan-peng Wang, Qiang-qiang Fan, Yuan Tian, Jing Sun, Xiao-fei Zhang, Jun-bo Zou, Jiang-xue Cheng, Fei Luan, Bing-tao Zhai
    Materials Today Bio.2024; 29: 101358.     CrossRef
  • Nanotechnology in cancer therapeutics, diagnosis, and management
    Disha Hazarika, Sumit Sarma, Priyanka Shankarishan
    BioTechnologia.2024; 105(3): 287.     CrossRef
  • Microwave‐Assisted Synthesis of Porous Biomolecule‐Incorporated Metal‐Organic Frameworks as Efficient Nanocarriers for Anti‐Cancer Drugs
    Trang Thi Thu Nguyen, Bao Quang Gia Le, Vy Tran Hanh Nguyen, Jae‐Hyoung Lee, Ngoc Xuan Dat Mai, Linh Ho Thuy Nguyen, Tan Le Hoang Doan
    ChemistrySelect.2023;[Epub]     CrossRef
  • Innovative nanotheranostics: Smart nanoparticles based approach to overcome breast cancer stem cells mediated chemo‐ and radioresistances
    Prithwish Kola, Prasanth Kumar Bhusetty Nagesh, Pritam Kumar Roy, K. Deepak, Rui Luis Reis, Subhas C. Kundu, Mahitosh Mandal
    WIREs Nanomedicine and Nanobiotechnology.2023;[Epub]     CrossRef
  • Nanoparticles in the diagnosis and treatment of cancer metastases: Current and future perspectives
    Mangala Hegde, Nikunj Naliyadhara, Jyothsna Unnikrishnan, Mohammed S. Alqahtani, Mohamed Abbas, Sosmitha Girisa, Gautam Sethi, Ajaikumar B. Kunnumakkara
    Cancer Letters.2023; 556: 216066.     CrossRef
  • Influence of lung cancer model characteristics on tumor targeting behavior of nanodrugs
    Weixia Xu, Shengmin Yang, Linwei Lu, Qianzhu Xu, Sunyi Wu, Jianfen Zhou, Jiashen Lu, Xingyan Fan, Nana Meng, Yuan Ding, Xudong Zheng, Weiyue Lu
    Journal of Controlled Release.2023; 354: 538.     CrossRef
  • Metastatic Breast Cancer: Review of Emerging Nanotherapeutics
    Ranga Dissanayake, Rheal Towner, Marya Ahmed
    Cancers.2023; 15(11): 2906.     CrossRef
  • Efficacy and Safety of Nanopaclitaxel Formulation for Cancer Treatment: Evidence From Randomized Clinical Trials
    Xiangmin Deng, Xiaoqin Huang, Xiaoyan Dong, Genxiang Mao, Wenmin Xing
    Nanomedicine.2023; 18(10): 833.     CrossRef
  • Combination Therapy as a Promising Way to Fight Oral Cancer
    João P. N. Silva, Bárbara Pinto, Luís Monteiro, Patrícia M. A. Silva, Hassan Bousbaa
    Pharmaceutics.2023; 15(6): 1653.     CrossRef
  • Nano delivery system for paclitaxel: Recent advances in cancer theranostics
    Na Ying, Sisi Liu, Mengmeng Zhang, Jing Cheng, Linghuan Luo, Jiayi Jiang, Gaofan Shi, Shu Wu, Jun Ji, Haoyuan Su, Hongzhi Pan, Dongdong Zeng
    Colloids and Surfaces B: Biointerfaces.2023; 228: 113419.     CrossRef
  • Current Perspectives on Paclitaxel: Focus on Its Production, Delivery and Combination Therapy
    Yibin Liu, Fenglan Zhao, Qibao Wang, Qingjie Zhao, Guige Hou, Qingguo Meng
    Mini-Reviews in Medicinal Chemistry.2023; 23(18): 1780.     CrossRef
  • Current perspectives and trends in nanoparticle drug delivery systems in breast cancer: bibliometric analysis and review
    Sheng Sun, Ye-hui Wang, Xiang Gao, He-yong Wang, Lu Zhang, Na Wang, Chun-mei Li, Shao-quan Xiong
    Frontiers in Bioengineering and Biotechnology.2023;[Epub]     CrossRef
  • Paclitaxel prodrug-encapsulated polypeptide micelles with redox/pH dual responsiveness for cancer chemotherapy
    Jinyu Liu, Yanhao Zhang, Chao Liu, Yuhao Jiang, Zihao Wang, Xinsong Li
    International Journal of Pharmaceutics.2023; 645: 123398.     CrossRef
  • Biodegradable polyester-based nano drug delivery system in cancer chemotherapy: a review of recent progress (2021–2023)
    Zongheng Wang, Miaomiao Xiao, Fangliang Guo, Yue Yan, Hong Tian, Qianshi Zhang, Shuangyi Ren, Liqun Yang
    Frontiers in Bioengineering and Biotechnology.2023;[Epub]     CrossRef
  • Comparison of triblock copolymeric micelles based on α- and ε-poly(L-lysine): a Cornelian choice
    Franck Marquet, Viorica Patrulea, Gerrit Borchard
    Polymer Journal.2022; 54(2): 199.     CrossRef
  • Current understandings and clinical translation of nanomedicines for breast cancer therapy
    Yike Jiang, Ziyi Jiang, Mingzhe Wang, Lan Ma
    Advanced Drug Delivery Reviews.2022; 180: 114034.     CrossRef
  • Poly(ϵ-Caprolactone)-Methoxypolyethylene Glycol (PCL-MPEG)-Based Micelles for Drug-Delivery: The Effect of PCL Chain Length on Blood Components, Phagocytosis, and Biodistribution
    Zemin Hou, Wencheng Zhou, Xi Guo, Rui Zhong, Ao Wang, Jiehua Li, Ying Cen, Chao You, Hong Tan, Meng Tian
    International Journal of Nanomedicine.2022; Volume 17: 1613.     CrossRef
  • Engineered nanomaterials as an effective tool for HER2+ breast cancer therapy
    Prashant Pandey, Dilip Kumar Arya, Mohan Kumar Ramar, Kumarappan Chidambaram, P.S. Rajinikanth
    Drug Discovery Today.2022; 27(9): 2526.     CrossRef
  • Biophysical Characterization of Interactions between Serum Albumin and Block Copolymer Micelles
    Catherine F. Dial, Richard A. Gemeinhart
    ACS Biomaterials Science & Engineering.2022; 8(7): 2899.     CrossRef
  • Micelles in Cancer Therapy: An Update on Preclinical and Clinical Status
    Rabia Aqeel, Nidhi Srivastava, Poonam Kushwaha
    Recent Patents on Nanotechnology.2022; 16(4): 283.     CrossRef
  • Challenging the fundamental conjectures in nanoparticle drug delivery for chemotherapy treatment of solid cancers
    Juanjuan Yang, Xiaojin Wang, Bingshun Wang, Kinam Park, Karen Wooley, Shiyi Zhang
    Advanced Drug Delivery Reviews.2022; 190: 114525.     CrossRef
  • In Vivo Sustained Release of the Retrograde Transport Inhibitor Retro-2.1 Formulated in a Thermosensitive Hydrogel
    Robin Vinck, Laetitia Anvi Nguyen, Mathilde Munier, Lucie Caramelle, Diana Karpman, Julien Barbier, Alain Pruvost, Jean-Christophe Cintrat, Daniel Gillet
    International Journal of Molecular Sciences.2022; 23(23): 14611.     CrossRef
  • Clinical Translation of Self‐Assembled Cancer Nanomedicines
    Peng Mi, Kanjiro Miyata, Kazunori Kataoka, Horacio Cabral
    Advanced Therapeutics.2021;[Epub]     CrossRef
  • From Conventional to Precision Therapy in Canine Mammary Cancer: A Comprehensive Review
    Guillermo Valdivia, Ángela Alonso-Diez, Dolores Pérez-Alenza, Laura Peña
    Frontiers in Veterinary Science.2021;[Epub]     CrossRef
  • Advanced Biotechnologies: Collections of Plant Cell Cultures As a Basis for Development and Production of Medicinal Preparations
    E. V. Popova, A. V. Nosov, M. V. Titova, D. V. Kochkin, A. A. Fomenkov, I. E. Kulichenko, A. M. Nosov
    Russian Journal of Plant Physiology.2021; 68(3): 385.     CrossRef
  • Reappraisal of anticancer nanomedicine design criteria in three types of preclinical cancer models for better clinical translation
    Xin Luan, Hebao Yuan, Yudong Song, Hongxiang Hu, Bo Wen, Miao He, Huixia Zhang, Yan Li, Feng Li, Pan Shu, Joseph P. Burnett, Nathan Truchan, Maria Palmisano, Manjunath P. Pai, Simon Zhou, Wei Gao, Duxin Sun
    Biomaterials.2021; 275: 120910.     CrossRef
  • Breast cancer: Muscarinic receptors as new targets for tumor therapy
    Alejandro Español, Agustina Salem, Yamila Sanchez, María Elena Sales
    World Journal of Clinical Oncology.2021; 12(6): 404.     CrossRef
  • Direct Comparison of Analogous Amphiphilic Gradient and Block Polyoxazolines
    Lenka Loukotová, Pavel Švec, Ondřej Groborz, Tomáš Heizer, Hynek Beneš, Helena Raabová, Tereza Bělinová, Vít Herynek, Martin Hrubý
    Macromolecules.2021; 54(17): 8182.     CrossRef
  • Challenges towards Targeted Drug Delivery in Cancer Nanomedicines
    Muhammad Nadeem Hafeez, Christian Celia, Vilma Petrikaite
    Processes.2021; 9(9): 1527.     CrossRef
  • Drug Delivery of Natural Products Through Nanocarriers for Effective Breast Cancer Therapy: A Comprehensive Review of Literature
    Kah Min Yap, Mahendran Sekar, Shivkanya Fuloria, Yuan Seng Wu, Siew Hua Gan, Nur Najihah Izzati Mat Rani, Vetriselvan Subramaniyan, Chandrakant Kokare, Pei Teng Lum, M Yasmin Begum, Shankar Mani, Dhanalekshmi Unnikrishnan Meenakshi, Kathiresan V Sathasiva
    International Journal of Nanomedicine.2021; Volume 16: 7891.     CrossRef
  • Phase II study of DHP107 (oral paclitaxel) in the first-line treatment of HER2-negative recurrent or metastatic breast cancer (OPTIMAL study)
    Sung-Bae Kim, Jae Hong Seo, Jin-Hee Ahn, Tae-Yong Kim, Seok Yun Kang, Joohyuk Sohn, Yaewon Yang, Kyong Hwa Park, Yong Wha Moon, Seungtaek Lim, Myoung Joo Kang, Koung Eun Yoon, Hyun Ju Cho, Keun Seok Lee
    Therapeutic Advances in Medical Oncology.2021;[Epub]     CrossRef
  • Self-assembly of oxidation-responsive polyethylene glycol-paclitaxel prodrug for cancer chemotherapy
    Chengyuan Dong, Quan Zhou, Jiajia Xiang, Fusheng Liu, Zhuxian Zhou, Youqing Shen
    Journal of Controlled Release.2020; 321: 529.     CrossRef
  • Clinical applications of nanomedicine in cancer therapy
    Mohammad Norouzi, Mehrnaz Amerian, Mahshid Amerian, Fatemeh Atyabi
    Drug Discovery Today.2020; 25(1): 107.     CrossRef
  • Improvement of Paclitaxel-Associated Adverse Reactions (ADRs) via the Use of Nano-Based Drug Delivery Systems: A Systematic Review and Network Meta-Analysis


    Pi-Ling Chou, Ya-Ping Huang, Meng-Hsuan Cheng, Kun-Ming Rau, Yi-Ping Fang
    International Journal of Nanomedicine.2020; Volume 15: 1731.     CrossRef
  • Quality of adverse event reporting in phase III randomized controlled trials of breast and colorectal cancer: A systematic review
    Adam S. Komorowski, Helen J. MacKay, Rossanna C. Pezo
    Cancer Medicine.2020; 9(14): 5035.     CrossRef
  • Nanotechnology for angiogenesis: opportunities and challenges
    Saeid Kargozar, Francesco Baino, Sepideh Hamzehlou, Michael R. Hamblin, Masoud Mozafari
    Chemical Society Reviews.2020; 49(14): 5008.     CrossRef
  • Furry nanoparticles: synthesis and characterization of nanoemulsion-mediated core crosslinked nanoparticles and their robust stability in vivo
    Rena Tanaka, Koichi Arai, Jun Matsuno, Miyo Soejima, Ji Ha Lee, Rintaro Takahashi, Kazuo Sakurai, Shota Fujii
    Polymer Chemistry.2020; 11(27): 4408.     CrossRef
  • Polymeric micelles for the delivery of poorly soluble drugs: From nanoformulation to clinical approval
    Duhyeong Hwang, Jacob D. Ramsey, Alexander V. Kabanov
    Advanced Drug Delivery Reviews.2020; 156: 80.     CrossRef
  • What Went Wrong with Anticancer Nanomedicine Design and How to Make It Right
    Duxin Sun, Simon Zhou, Wei Gao
    ACS Nano.2020; 14(10): 12281.     CrossRef
  • Synthesis of PCL–PEG–PCL Triblock Copolymer via Organocatalytic Ring-Opening Polymerization and Its Application as an Injectable Hydrogel—An Interdisciplinary Learning Trial
    Kaiting Wu, Lin Yu, Jiandong Ding
    Journal of Chemical Education.2020; 97(11): 4158.     CrossRef
  • Phytochemical-Based Nanomedicine for Advanced Cancer Theranostics: Perspectives on Clinical Trials to Clinical Use


    Madhusmita Dhupal, Devasish Chowdhury
    International Journal of Nanomedicine.2020; Volume 15: 9125.     CrossRef
  • A Compressive Review about Taxol®: History and Future Challenges
    Julia Gallego-Jara, Gema Lozano-Terol, Rosa Alba Sola-Martínez, Manuel Cánovas-Díaz, Teresa de Diego Puente
    Molecules.2020; 25(24): 5986.     CrossRef
  • Recent Clinical Developments of Nanomediated Drug Delivery Systems of Taxanes for the Treatment of Cancer
    Ruben AG van Eerden, Ron HJ Mathijssen, Stijn LW Koolen
    International Journal of Nanomedicine.2020; Volume 15: 8151.     CrossRef
  • Basic principles of drug delivery systems – the case of paclitaxel
    S. Ezrahi, A. Aserin, N. Garti
    Advances in Colloid and Interface Science.2019; 263: 95.     CrossRef
  • Biomolecules Turn Self-Assembling Amphiphilic Block Co-polymer Platforms Into Biomimetic Interfaces
    Saziye Yorulmaz Avsar, Myrto Kyropoulou, Stefano Di Leone, Cora-Ann Schoenenberger, Wolfgang P. Meier, Cornelia G. Palivan
    Frontiers in Chemistry.2019;[Epub]     CrossRef
  • Polyester Nanoparticle Encapsulation Mitigates Paclitaxel-Induced Peripheral Neuropathy
    R. Ganugula, M. Deng, M. Arora, H.-L. Pan, M. N. V. Ravi Kumar
    ACS Chemical Neuroscience.2019; 10(3): 1801.     CrossRef
  • PEGylation of Ginsenoside Rg3-Entrapped Bovine Serum Albumin Nanoparticles: Preparation, Characterization, and In Vitro Biological Studies
    Lijun Zhang, Junfeng Hui, Pei Ma, Yu Mi, Daidi Fan, Chenhui Zhu, Lei Chi, Yanan Dong
    Journal of Nanomaterials.2019; 2019: 1.     CrossRef
  • Prevention of paclitaxel-induced neuropathy by formulation approach
    Xiaowei Zang, Jong Bong Lee, Kiran Deshpande, Olga B. Garbuzenko, Tamara Minko, Leonid Kagan
    Journal of Controlled Release.2019; 303: 109.     CrossRef
  • Current status of nanomedicine in the chemotherapy of breast cancer
    A. I. Fraguas-Sánchez, C. Martín-Sabroso, A. Fernández-Carballido, A. I. Torres-Suárez
    Cancer Chemotherapy and Pharmacology.2019; 84(4): 689.     CrossRef
  • A Phase II Study of Genexol-PM and Cisplatin as Induction Chemotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma
    Bhumsuk Keam, Keun-Wook Lee, Se-Hoon Lee, Jin-Soo Kim, Jin Ho Kim, Hong-Gyun Wu, Keun-Yong Eom, Suzy Kim, Soon-Hyun Ahn, Eun-Jae Chung, Seong Keun Kwon, Woo-Jin Jeong, Young Ho Jung, Ji-Won Kim, Dae Seog Heo
    The Oncologist.2019; 24(6): 751.     CrossRef
  • Advances in thermosensitive polymer-grafted platforms for biomedical applications
    Phung Ngan Le, Chan Khon Huynh, Ngoc Quyen Tran
    Materials Science and Engineering: C.2018; 92: 1016.     CrossRef
  • Supramolecular polymeric chemotherapy based on cucurbit[7]uril-PEG copolymer
    Hao Chen, Yueyue Chen, Han Wu, Jiang-Fei Xu, Zhiwei Sun, Xi Zhang
    Biomaterials.2018; 178: 697.     CrossRef
  • pH/NIR-Responsive Polypyrrole-Functionalized Fibrous Localized Drug-Delivery Platform for Synergistic Cancer Therapy
    Arjun Prasad Tiwari, Tae In Hwang, Jung-Mi Oh, Bikendra Maharjan, Sungkun Chun, Beom Su Kim, Mahesh Kumar Joshi, Chan Hee Park, Cheol Sang Kim
    ACS Applied Materials & Interfaces.2018; 10(24): 20256.     CrossRef
  • The Blood Clearance Kinetics and Pathway of Polymeric Micelles in Cancer Drug Delivery
    Xuanrong Sun, Guowei Wang, Hao Zhang, Shiqi Hu, Xin Liu, Jianbin Tang, Youqing Shen
    ACS Nano.2018; 12(6): 6179.     CrossRef
  • Different Nanoformulations Alter the Tissue Distribution of Paclitaxel, Which Aligns with Reported Distinct Efficacy and Safety Profiles
    Feng Li, Huixia Zhang, Miao He, Jinhui Liao, Nianhang Chen, Yan Li, Simon Zhou, Maria Palmisano, Alex Yu, Manjunath P. Pai, Hebao Yuan, Duxin Sun
    Molecular Pharmaceutics.2018; 15(10): 4505.     CrossRef
  • Emerging advances in P-glycoprotein inhibitory nanomaterials for drug delivery
    Longfa Kou, Rui Sun, Yangzom D. Bhutia, Qing Yao, Ruijie Chen
    Expert Opinion on Drug Delivery.2018; 15(9): 869.     CrossRef
  • The battle of “nano” paclitaxel
    Alexandros Marios Sofias, Michael Dunne, Gert Storm, Christine Allen
    Advanced Drug Delivery Reviews.2017;[Epub]     CrossRef
  • Overcoming the Road Blocks: Advancement of Block Copolymer Micelles for Cancer Therapy in the Clinic
    Loujin Houdaihed, James C. Evans, Christine Allen
    Molecular Pharmaceutics.2017; 14(8): 2503.     CrossRef
  • PEG-PCL-based nanomedicines: A biodegradable drug delivery system and its application
    Philip Grossen, Dominik Witzigmann, Sandro Sieber, Jörg Huwyler
    Journal of Controlled Release.2017; 260: 46.     CrossRef
  • Effect of Thermoresponsive Poly(L-lactic acid)–poly(ethylene glycol) Gel Injection on Left Ventricular Remodeling in a Rat Myocardial Infarction Model
    Shota Somekawa, Atsushi Mahara, Kazunari Masutani, Yoshiharu Kimura, Hiroshi Urakawa, Tetsuji Yamaoka
    Tissue Engineering and Regenerative Medicine.2017; 14(5): 507.     CrossRef
  • A versatile nanoplatform for synergistic combination therapy to treat human esophageal cancer
    Xin-shuai Wang, De-jiu Kong, Tzu-yin Lin, Xiao-cen Li, Yoshihiro Izumiya, Xue-zhen Ding, Li Zhang, Xiao-chen Hu, Jun-qiang Yang, She-gan Gao, Kit S Lam, Yuan-pei Li
    Acta Pharmacologica Sinica.2017; 38(6): 931.     CrossRef
  • 22,230 View
  • 697 Download
  • 100 Web of Science
  • 96 Crossref
Close layer

Cancer Res Treat : Cancer Research and Treatment
Close layer
TOP